Find Reports
Select Report Type
Reimbursement Review
Displaying 726 - 750 of 1258
Please scroll or swipe to the right to view the full content.
| Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|
| Jetrea | Ocriplasmin | Vitreomacular adhesion | List with criteria/condition | Complete | SR0337-000 | |||
| Adcetris | Brentuximab vedotin | Systemic Anaplastic Large Cell Lymphoma | Reimburse with clinical criteria and/or conditions | Complete | PC0021-000 | |||
| Tafinlar | Dabrafenib | Metastatic Melanoma | Reimburse with clinical criteria and/or conditions | Complete | PC0025-000 | |||
| Alimta | Pemetrexed | Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0027-000 | |||
| Fibristal | Ulipristal acetate | Uterine fibroids | List with criteria/condition | Complete | SR0326-000 | |||
| Onglyza | Saxagliptin | Diabetes mellitus, type 2 | List with criteria/condition | Complete | SR0329-000 | |||
| Stivarga (CRC) | Regorafenib | Metastatic Colorectal Cancer | Do not reimburse | Complete | PC0026-000 | |||
| Mekinist | Trametinib | Metastatic Melanoma | Reimburse with clinical criteria and/or conditions | Complete | PC0030-000 | |||
| Revlimid | Lenalidomide | Multiple Myeloma (as maintenance therapy) | Reimburse with clinical criteria and/or conditions | Complete | PC0029-000 | |||
| Zytiga | Abiraterone acetate | Metastatic Castration Resistant Prostate Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0028-000 | |||
| Jentadueto | Linagliptin-metformin | Diabetes mellitus, type 2 | List with criteria/condition | Complete | SR0306-000 | |||
| Fycompa | Perampanel | Epilepsy, partial onset seizures | List with criteria/condition | Complete | SR0316-000 | |||
| Edarbi | Azilsartan medoxomil | Hypertension | Do not list at the submitted price | Complete | SR0317-000 | |||
| Edarbyclor | Azilsartan medoxomil + chlorthalidone | Hypertension | Do not list | Complete | SR0318-000 | |||
| Tecfidera | Dimethyl fumarate | Multiple sclerosis, relapsing-remitting | List with criteria/condition | Complete | SR0309-000 | |||
| Afinitor | Everolimus | Renal angiomyolipoma associated with tuberous sclerosis complex (TSC) | Do not list | Complete | SR0315-000 | |||
| Sublinox | Zolpidem tartrate | Insomnia | Do not list | Complete | SR0314-000 | |||
| Adcetris | Brentuximab vedotin | Hodgkin Lymphoma | Reimburse with clinical criteria and/or conditions | Complete | PC0020-000 | |||
| Votrient | Pazopanib hydrochloride | Metastatic Renal Cell Carcinoma | Reimburse | Complete | PC0022-000 | |||
| Rebif | Interferon beta-1a | Clinically isolated syndrome | Do not list | Complete | SR0298-000 | |||
| Perjeta Herceptin Combo Pack | Pertuzumab | Metastatic Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0018-000 | |||
| Xtandi | Enzalutamide | Metastatic Castration Resistant Prostate Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0023-000 | |||
| Orencia | Abatacept | Arthritis, rheumatoid | List with clinical criteria and/or conditions | Complete | SR0299-000 | |||
| Soliris | Eculizumab | Hemolytic Uremic Syndrome, Atypical | Do not list | Complete | SR0304-000 | |||
| Humira | Adalimumab | Arthritis, juvenile idiopathic | List with clinical criteria and/or conditions | Complete | SR0308-000 |
Health Technology Review
Displaying 576 - 589 of 589
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 40 of 40
View All Reports
Displaying 726 - 750 of 2093
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Vagus Nerve Stimulation for the Treatment of Post–COVID-19 Condition | Horizon Scan | Health Technology Update | Active | EN0040-000 | |||
| Therapeutic Support for Pressure Injuries | Health Technology Review | Rapid Review | Completed | RC1450-000 | |||
| Airway Pressure Release Ventilation for Acute Respiratory Distress Syndrome: An Update | Health Technology Review | Rapid Review | Completed | RC1451-000 | |||
| cenegermin | Reimbursement Review | Complete | SR0704-000 | ||||
| avalglucosidase alfa | Reimbursement Review | Complete | SR0703-000 | ||||
| Antiviral Prophylaxis With Tenofovir for Patients With History of Hepatitis B Receiving Oncology Drug Treatment | Health Technology Review | Rapid Review | Completed | RC1448-000 | |||
| RWE Learning Project Non-Oncology: Ocaliva | Health Technology Review | Technology Review | In Progress | HC0046-000 | |||
| Renal Cell Carcinoma (RCC) | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0013-000 | |||
| tirzepatide | Reimbursement Review | Cancelled | SR0751-000 | ||||
| Considerations for the use of COVID-19 Rapid Tests | Health Technology Review | Environmental Scan | Completed | ES0364-000 | |||
| Utilization of Glucagon-Like Peptide-1 Receptor Agonists | Health Technology Review | Technology Review | Completed | HC0042-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 31 | Reimbursement Review | Pharmaceutical Review Update | |||||
| cemiplimab | Reimbursement Review | Complete | PC0262-000 | ||||
| amifampridine phosphate | Reimbursement Review | Complete | SR0664-000 | ||||
| tafamidis | Reimbursement Review | Complete | SF0722-000 | ||||
| ripretinib | Reimbursement Review | Complete | PC0265-000 | ||||
| Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes | Health Technology Review | Rapid Review | Completed | RC1442-000 | |||
| Health Technology Assessment Recommendations and Managed Entry Agreements Related to Optimizing the Treatment for Pediatric Spinal Muscular Atrophy | Health Technology Review | Environmental Scan | In Progress | ES0368-000 | |||
| Virtual Care Use in Primary Care or Specialty Care Settings | Health Technology Review | Rapid Review | Completed | RC1444-000 | |||
| Concurrent or Sequential Administration of Drugs for COVID-19 and Influenza | Health Technology Review | Rapid Review | Completed | RC1446-000 | |||
| Liposuction for Lipedema: A 2022 Update | Health Technology Review | Rapid Review | Completed | RC1447-000 | |||
| ospemifene | Reimbursement Review | Complete | SR0709-000 | ||||
| Mesalamine for the Treatment of Crohn Disease | Health Technology Review | Rapid Review | Completed | RC1445-000 | |||
| An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Care | Horizon Scan | Emerging Health Technologies | Completed | EH0106-000 | |||
| Understanding the Portrait of Dementia Care in Canada: Our Panel of Experts | Horizon Scan | Emerging Health Technologies | Completed | EH0110-000 |